Fierce Healthcare March 20, 2023
States have been grappling with rising Medicaid drug costs for the past several years. A new report from the Medicaid and CHIP Payment and Access Commission gives some recommendations on how to handle the issue. (Getty/Charles Wollertz)
Congress should give states the power to not pay full price under Medicaid for drugs approved under the Food and Drug Administration’s accelerated approval pathway, a key advisory panel said.